1. Introduction
===============

Canine enteric coronavirus (CECoV) is a common pathogen of dogs. Disease is typified by mild enteritis; however sporadic outbreaks, usually in puppies, of haemorrhagic and fatal enteritis have been attributed to CECoV ([@bib4], [@bib8], [@bib14]). Severe disease outbreaks appear to be associated with the evolution of novel highly pathogenic strains of CECoV ([@bib5]). Coinfection with other enteric pathogens such as canine parvovirus appears to have a synergistic effect ([@bib21]).

CECoV has recently been found to exist in two closely related forms. The original strain is now designated as type II CECoV, whereas the more recently identified strain, first reported in 2003, is known as type I CECoV ([@bib18]). The strains are named in this way due to their respective homologies to types II and I feline coronavirus (FCoV) ([@bib9]). Infection may occur with a single strain, however mixed infections with both types appear to be common ([@bib6]). CECoV is distinct from the newly recognised canine respiratory coronavirus (CRCoV), which is implicated in the canine infectious respiratory disease complex and falls into a separate group of the coronavirus family ([@bib7]).

A range of methodologies has been used to assess the prevalence of both types I and II CECoV in different dog populations. Seroprevalence estimates using type II-based assays range between 16% and 94% ([@bib13], [@bib31]), with kennelled dogs tending to show a higher prevalence. In diarrhoeic dogs the prevalence of CECoV by RT-PCR has been reported to range from 15% to 42% in pet dogs ([@bib1], [@bib15], [@bib31]) and up to 73% in kennelled dogs ([@bib24]).

There is little data on the prevalence of CECoV infection in dogs without enteric disease, and what is available is based on virus isolation, which can only detect type II CECoV, or electron microscopy, which is relatively insensitive ([@bib28], [@bib23]). This leaves a significant gap in our understanding of the epidemiology of this disease in the dog population as a whole. In order to address this deficiency, we have carried out a cross-sectional study of CECoV carriage as determined by RT-PCR in dogs presenting for any reason at randomly selected veterinary practices across the UK.

2. Materials and methods
========================

One veterinary practice was recruited by random selection from each of the twenty-three regions of the United Kingdom (as defined by the Royal College of Veterinary Surgeons register) in order to source a wide geographical distribution of samples.

Participating veterinarians were requested to enrol a cross-section of twenty-five dogs visiting for any reason to reflect the clientele and caseload of their surgery: it was not feasible to select the study dogs randomly whilst maintaining compliance. From each sampled dog, a faecal sample was collected and sent by post, along with a brief questionnaire to elicit information such as age, breed, sex, reason for visit and any recent history of enteric disease.

At the laboratory, samples were homogenised in a 10% dilution of minimum essential medium with 10% foetal calf serum, clarified by centrifugation and genetic material extracted using the Qiamp Viral RNA mini kit (Qiagen) as recommended by the manufacturer. Reverse transcription was carried out using random primers and Superscript III MuLV Reverse Transcriptase (Invitrogen), according to the manufacturer\'s instructions.

A 409 bp fragment of the M gene was amplified by PCR, using Thermoprime Plus DNA polymerase with 10× ReddyMix PCR buffer (Abgene), and the primer pair CCOV1/CCOV2 ([@bib20]). These primers have previously been successfully used to detect both types I and II CECoV ([@bib2]). Negative controls and at least one positive control were included at every stage, from RNA extraction to PCR. The positive control comprised a faecal sample, either spiked with CECoV C54 (type II, available from the start of the study) or naturally infected with CECoV 07-019 (type I, became available during the course of the study).

The PCR products were purified (QIAquick PCR purification kit; Qiagen) and sequenced bi-directionally using primers CCOV1 and CCOV2 according to standard protocols (ABI Prism BigDye terminators version 3.0 cycle sequencing kits; Applied Biosystems). For each amplicon, a consensus sequence was produced using ChromasPro version 1.32 (Technelysium Ptl Ltd.). Ambiguities identified consistently in both strands were included in the consensus sequence. All primer sites were removed prior to analysis, resulting in a final useable sequence of 316 nucleotides, corresponding to nucleotides 379--694 of CCoV type I 259/01 (accession af502583) and nucleotides 6782 to 7094 of CCoV type II INSAVC (accession [D13096](ncbi-n:D13096)). Sequences have been submitted to Genbank ([EU339175](ncbi-n:EU339175)--[EU339181](ncbi-n:EU339181)).

Sequence alignments, nucleotide distance calculations (Jukes-Cantor), and phylogenetic analysis were performed using MEGA version 4.0 ([@bib26]). Support for individual nodes was sought by bootstrap analysis using 1000 repetitions.

Statistical analysis was performed using SPSS for Windows, Rel. 14.0.0 2005, Chicago SPSS Inc. Data were analysed using Chi-squared and Fisher\'s exact tests.

3. Results
==========

Two hundred and forty-nine samples were obtained from twenty practices ([Fig. 1](#fig1){ref-type="fig"} ); numbers submitted varied from 3 to 33, with a mean of 12 per practice.Fig. 1Map of the United Kingdom. Squares show approximate locations of participating practices. Black squares indicate practices which submitted positive samples; grey squares indicate all other participating practices. Rooted neighbour-joining tree of the seven partial M gene sequences generated in this study and published reference canine, feline and human coronaviruses (outgroup). All branch lengths are proportional to distances established using the Jukes--Cantor method. Bootstraps are expressed as percentages, and only included where greater than 75%. Key: HCoV NL63 accession [DQ445912](ncbi-n:DQ445912), FCoV C1Je accession [DQ848678](ncbi-n:DQ848678); FCoV 1146 accession [DQ010921](ncbi-n:DQ010921); FCoV DF-2 accession [DQ286389](ncbi-n:DQ286389); CECoV BGF10 accession [AY342160](ncbi-n:AY342160); CECoV 259/01 accession [AF502583](ncbi-n:AF502583); CECoV 23/03 accession [AY548235](ncbi-n:AY548235); CECoV INSAVC accession [D13096](ncbi-n:D13096). Samples from this study are coded CECoV *x*--*y*, where *x* is the internally designated practice number, and *y* the individual dog reference.

3.1. Characteristics of the sample population
---------------------------------------------

Of the 249 dogs sampled, 111 (44.6%) were male, 134 (53.8%) female and for 4 (1.6%) the sex was not specified. Dogs ranging from 2 months to 18 years of age were sampled. The age distribution was right-skewed (i.e. the tail is on the right) ([Fig. 2](#fig2){ref-type="fig"} ). This contrasts with findings from a door-to-door questionnaire study in which the age distribution of the pet dogs formed a normal distribution ([@bib29]). This contrast may reflect the large number of routine veterinary visits which many dogs undergo early in life for puppy checks, primary vaccination and neutering; however it may also reflect possible bias in the selection of cases by veterinarians.Fig. 2Histogram to show age distribution of dogs sampled in a cross-sectional study of 249 dogs from 20 UK veterinary practices. Data missing from one dog, therefore total number of dogs included is 248.

The majority of the dogs (144, 57.8%) were from single-dog households. Fifty-four (21.7%) were from two-dog households, and the remaining 51 (20.5%) came from households containing three or more dogs. This contrasts with previous data from a community-based survey of dog-ownership in which 77% of the households had a single dog, with 20% and 3% having two dogs and three or more dogs, respectively ([@bib30]). This may reflect the fact that a domestic door-to-door questionnaire would be likely to miss farms, commercial kennels and breeding premises. The breeds sampled are shown in [Fig. 3](#fig3){ref-type="fig"} . Apart from cross-breeds and Great Danes, all of the breeds most commonly sampled correspond to the 20 breeds most frequently registered in 2006 ([@bib10]).Fig. 3Histogram to show distribution of most common breeds of dog sampled in a cross-sectional study of 249 dogs from 20 UK veterinary practices. 202 dogs are included; breed was not specified for 47 dogs. Breeds with less than 4 dogs sampled are grouped under 'other breeds'.

Numerous conditions were given as the primary reason for taking the dog to the veterinary surgeon. The most common reasons in the 228 dogs for which a specific reason was given are shown in [Fig. 4](#fig4){ref-type="fig"} . The most common reason was vaccination (18.4%, 42/228), followed by 'routine' (which included weight check, claw clip, parasite treatment or social reasons such as accompanying another dog) and ear/skin problems, each of which were cited as the reason for visit in 12.7% (29/228) of the dogs surveyed. 7% (16/228) presented for diarrhoea, with or without vomiting.Fig. 4Bar chart to show the reasons for visit cited by study participants. This data was available for 228 dogs. \*Routine includes weight check, claw clip, flea/worm treatment and social reasons for visiting the surgery. ^\#^Sick dog included a broad range of diagnoses such as pyometra, false pregnancy, and convulsions. Conditions classified as 'misc' (miscellaneous) were those where the health status of the dog was impossible to determine, e.g. 'operation' which could refer to an elective or emergency surgery.

3.2. Prevalence of CECoV
------------------------

Of the 249 samples obtained, seven were positive for CECoV, a prevalence of 2.8% (95% confidence intervals 1.1--5.7). Three of the positive samples (sample numbers 01-033, 01-039 and 01-046) were obtained from dogs from the same multi-dog breeding household ([Fig. 1](#fig1){ref-type="fig"}). The other four were from different households with a wide geographical distribution. Samples 12-020 and 12-030 were from pups of less than 6 months of age; all of the other positive samples were from dogs aged 6--11 years. Three of the seven positive dogs (sample numbers 06-018, 07-019 and 12-020) had a history of diarrhoea within the previous month ([Table 1](#tbl1){ref-type="table"} ), although none of the seven presented at the surgery for diarrhoea. There was no significant association between either presenting for, or having a history of, recent diarrhoea and being CECoV positive (*p*  = 0.4) ([Table 1](#tbl1){ref-type="table"}), although with such a small number of positive samples, it would have been difficult to detect a statistically significant association.Table 1Numbers of dogs with and without recent diarrhoea sampled in a cross-sectional study of 249 dogs from 20 UK veterinary practices.CECoV positiveCECoV negativeTotalDiarrhoea as presenting complaint01616Owner-reported diarrhoea within previous month35255No history of recent diarrhoea4173177  Total7241248[a](#tbl1fn1){ref-type="table-fn"}[^1]

When sequenced, all seven positive samples grouped with type I CECoV in the M gene region ([Fig. 1](#fig1){ref-type="fig"}). No type II CECoV was obtained from any of the samples. Sequence analysis and retrospective testing of the positive samples with a real-time PCR assay (adapted for use in our laboratory, [@bib6]) confirmed that none of the positive samples contained mixed type I/type II infections.

As the prevalence of infection was lower than anticipated, further investigations were carried out to confirm the validity of the methods used. In the 233/249 samples for which the data was available, 93.1% of the samples were received by the laboratory within 4 days, with a median time in transit in the post of 2 days ([Fig. 5](#fig5){ref-type="fig"} ). A loss of titre during transportation was therefore considered possible. However, in pilot experiments, a \<10-fold loss in sensitivity was found, using the conventional PCR assay, when CECoV spiked faecal samples were left at room temperature for 7 days ([Fig. 6](#fig6){ref-type="fig"} ). As 98.3% of the samples were received at the laboratory within 7 days of collection, this time delay is unlikely to have been a major contributory factor to the low prevalence detected, although some potential effect cannot be ruled out in those few samples which were delayed in the post for longer periods.Fig. 5Histogram to show the length of time between collection of each faecal sample and receipt at the laboratory. Data was available for 233/249 samples submitted.Fig. 6Faeces spiked with CECoV-C54 were kept at room temperature for a number of days and then underwent RT-PCR using the protocol described. It can be seen that even after 7 days a faint band was visible at the −3 dilution, suggesting a loss in titre of less than 10-fold.

The sensitivity of the conventional PCR assay used was also examined in relation to the real-time PCR assay of [@bib6], and was found to have a similar sensitivity for the detection of type I, type II, and mixed infections. The sensitivity was equivalent to 100--1000 RNA copies per μl of cDNA for the conventional PCR, as compared to 100 RNA copies per μl of cDNA in the real-time PCR. In addition, both assays (real-time and conventional) have subsequently been used on samples from 166 kennelled dogs, where the prevalence of CECoV carriage was expected to be high. Overall concordance between the two assays was 96% (160/166). Of these, 30 were CECoV positive by both methods (9 type I, 6 type II and 15 mixed), four by real-time PCR alone (2 type I, 1 type II, 1 mixed) and two by conventional PCR alone, presumably due to primer or probe binding site mismatches.

It was therefore concluded that the sensitivity and specificity of the methods used were broadly comparable to that of the real-time PCR.

4. Discussion
=============

Although the importance of CECoV as a canine pathogen is being increasingly recognised, its prevalence is poorly understood. Most studies have focussed on diarrhoeic or kennelled dogs, and there is little data on the prevalence of CECoV in the wider dog population, including healthy pet dogs. Such information is, however, important in increasing our understanding of the epidemiology of the disease. In the present study, we have targeted this population of both asymptomatic and diarrhoeic dogs through a cross-sectional study survey of randomly selected veterinary practices from throughout the UK. In order to maximise compliance, random selection was not used at the client level, and it is possible that this may have caused some bias.

Despite the large number of dogs sampled in our study, the prevalence estimate obtained was relatively low (2.8%). There are few studies on prevalence in comparable dog populations, but in a small study in Liverpool using virus isolation, no CECoV was obtained from 26 healthy pet dogs in a boarding kennel, although eight of 32 dogs with acute diarrhoea were positive for type II CECoV in the same study ([@bib28]). This contrasts with a more recent study in which a prevalence of 17.5% was detected by electron microscopy in 200 healthy dogs in Germany ([@bib23]). The variability of prevalence estimates depends on factors such as the detection methods used and the characteristics and disease status of the dog population under study. In addition, it is possible that the prevalence of CECoV in a population might fluctuate over time and that any prevalence estimate will be dependent on the timing of sampling.

Although 28.6% of the 248 dogs for which data was available either had diarrhoea at the time of sampling or a recent history of diarrhoea, no significant association was detected with CECoV shedding when compared to animals with no history of diarrhoea. However, the number of CECoV positive dogs in our study was small, and this makes the power to detect an association low. There are a number of possible reasons why relatively few diarrhoeic dogs were positive for CECoV in our study. Mild diarrhoea in dogs is very often non-infectious in origin and in some cases may simply be a natural sequel to dietary indiscretion. Alternatively, other pathogens may have been involved, or if the diarrhoea had been coronaviral in origin, virus shedding may have stopped by the time of sampling.

Interestingly however, although overall there was no significant association between being CECoV positive and having diarrhoea, three of the seven positive dogs (all three coming from different households) had had diarrhoea within the previous month. It is not clear whether these seven dogs were undergoing acute asymptomatic infection or more chronic shedding. Dogs have been shown to shed CECoV for a variable but potentially long time following infection and clinical resolution ([@bib6]). In one natural infection study, one animal was reported to shed CECoV for up to 156 days even though signs of clinical disease only lasted for 10 days post-infection ([@bib17]). Such clinically normal carriers are likely to be important in maintaining infection in the general dog population.

This study reports the first identification of type I CECoV in the UK. No type II CECoV was identified from any of the samples in this study, although the same assay has been successfully used in our laboratory to detect both types I and II CECoV in other samples from UK dogs. There is some suggestion that type I CECoV may be shed at higher titres and for a longer period than type II, and if this is indeed the case this could lead to an enhanced probability of detecting type I CECoV in a cross-sectional study of this kind ([@bib6]). Type 1 CECoV virus was first described in 2003 in Italy ([@bib19]) and has since been reported in other countries ([@bib31], [@bib22]). Recent evidence, based on the discovery of a new open reading frame present in type I CECoV ([@bib11], [@bib25]), with residual fragments in type II CECoV, and the closely related feline coronavirus and transmissible gastroenteritis virus, suggests that type I CECoV may actually represent the ancestral virus of this group ([@bib12]).

The clinical significance of the distinction between types I and II CECoV is not clear. Although classic CECoV infection is considered to cause only mild enteric disease ([@bib27]), there are several reports where type II CECoV has been associated with more severe haemorrhagic diarrhoea and occasional death ([@bib3], [@bib4], [@bib32]). It has also been suggested that such signs can be seen with type I ([@bib2]). Since more virulent strains appear to evolve spontaneously ([@bib5], [@bib32]), it may be that both types I and II have the ability to cause a wide spectrum of clinical manifestations, and this variation in virulence may depend on both viral evolution and host factors such as age and immune status. Further work is needed on different populations of dogs to help clarify this.

Recognition of CECoV in practice is hampered by the fact that commercial diagnostic tests suitable for the detection of types I and II CECoV are not widely available. Electron microscopy is relatively insensitive, and serological assays are based on type II CECoV, which limits their use as they have unknown efficacy in detecting type I. In addition, since seroprevalence in the general dog population is relatively high, such tests are difficult to interpret in relation to diagnosing acute disease unless paired samples are taken. The efficacy of currently available CECoV vaccines, which are all based on type II CECoV, is also unclear. The only data on cross-protection available to date is based on *in vitro* work and suggests that the level of antigenic cross-reactivity between the two types may be limited ([@bib16]). Clearly, this should also be assessed in challenge experiments in vivo.

In conclusion, we have shown that the newly recognised type I CECoV is circulating at a low prevalence among clinically normal adult dogs in the UK. Previous studies have concentrated on kennelled dogs, and dogs with disease, which are known to be at high risk of infection ([@bib13], [@bib24]). Subclinically infected animals within the general dog population, as identified by this study, may represent an important reservoir of infection, playing a significant role in the epidemiology of this disease and the evolution of the virus.
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[^1]: One negative sample had missing questionnaire data.
